Lista de obras -

A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus

artículo científico publicado en 2003

Acupuncture and Moxibustion in the Treatment of Active Crohn’s Disease: A Randomized Controlled Study

artículo científico publicado en 2004

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care

artículo científico publicado en 2011

Analysis of HLA class I and II alleles in sporadic inclusion-body myositis

artículo científico publicado en 2003

Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials

artículo científico publicado en 2007

Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

artículo científico publicado en 2008

Augmentation as a treatment complication of restless legs syndrome: concept and management

artículo científico publicado en 2007

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine

artículo científico publicado en 2012

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment

artículo científico

Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics

artículo científico publicado en 2007

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

artículo científico publicado en 2007

Do occlusal splints have an effect on complex regional pain syndrome? A randomized, controlled proof-of-concept trial.

artículo científico publicado en 2008

Dopamine agonists for the treatment of restless legs syndrome

artículo científico publicado en 2011

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

artículo científico publicado en 2010

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression

artículo científico publicado en 2003

Efficacy and safety of dopamine agonists in restless legs syndrome ⬇️

artículo científico publicado el 27 de enero de 2012

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2008

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

artículo científico publicado en 2012

Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.

artículo científico publicado en 2014

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial

artículo científico publicado en 2005

Hydrocortisone concentration influences time to clinically significant healing of acute inflammation of the ocular surface and adnexa - results from a double-blind randomized controlled trial

artículo científico publicado en 2014

Identifying depression in primary care: a comparison of different methods in a prospective cohort study

artículo científico publicado en 2003

Levodopa for the treatment of restless legs syndrome

artículo científico publicado en 2011

Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial

artículo científico publicado en 2004

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

artículo científico publicado en 2008

One‐year treatment with standard and sustained‐release levodopa: Appropriate long‐term treatment of restless legs syndrome? ⬇️

artículo científico publicado el 1 de octubre de 2003

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

artículo científico publicado en 2004

Placebo or Active Control Trials of Antipsychotic Drugs? ⬇️

artículo científico publicado el 1 de mayo de 2003

Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).

artículo científico publicado en 2015

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

artículo científico publicado en 2009

Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study ⬇️

artículo científico publicado el 20 de septiembre de 2011

Rating of daytime and nighttime symptoms in RLS: validation of the RLS-6 scale of restless legs syndrome/Willis-Ekbom disease

artículo científico publicado en 2015

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study ⬇️

artículo científico publicado el 28 de diciembre de 2010

Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study

artículo científico publicado en 2010

Successful treatment of blepharitis with bibrocathol (Posiformin® 2 %).

artículo científico publicado en 2012

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

artículo científico publicado en 2013

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

artículo científico publicado en 2013

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

artículo científico publicado en 2010

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

artículo científico publicado en 2007

Validation of the Kohnen Restless Legs Syndrome-Quality of Life instrument

artículo científico publicado en 2016

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease) ⬇️

artículo científico publicado el 1 de julio de 2013

What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications

artículo científico publicado en 2013

Lista de obras de

A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus

Acupuncture and Moxibustion in the Treatment of Active Crohn’s Disease: A Randomized Controlled Study

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care

Analysis of HLA class I and II alleles in sporadic inclusion-body myositis

Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials

Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

Augmentation as a treatment complication of restless legs syndrome: concept and management

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment

Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

Do occlusal splints have an effect on complex regional pain syndrome? A randomized, controlled proof-of-concept trial.

Dopamine agonists for the treatment of restless legs syndrome

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression

Efficacy and safety of dopamine agonists in restless legs syndrome ⬇️

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial

Hydrocortisone concentration influences time to clinically significant healing of acute inflammation of the ocular surface and adnexa - results from a double-blind randomized controlled trial

Identifying depression in primary care: a comparison of different methods in a prospective cohort study

Levodopa for the treatment of restless legs syndrome

Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

One‐year treatment with standard and sustained‐release levodopa: Appropriate long‐term treatment of restless legs syndrome? ⬇️

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

Placebo or Active Control Trials of Antipsychotic Drugs? ⬇️

Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study ⬇️

Rating of daytime and nighttime symptoms in RLS: validation of the RLS-6 scale of restless legs syndrome/Willis-Ekbom disease

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study ⬇️

Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study

Successful treatment of blepharitis with bibrocathol (Posiformin® 2 %).

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

Validation of the Kohnen Restless Legs Syndrome-Quality of Life instrument

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease) ⬇️

What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications